Close Menu
Finletix
  • Home
  • AI
  • Financial
  • Investments
  • Small Business
  • Stocks
  • Tech
  • Marketing
What's Hot

Nvidia’s AI empire: A look at its top startup investments

October 12, 2025

I Used ChatGPT to Plan a Trip to Tunisia, While My Partner Used Claude

October 12, 2025

I Turned Down NYU for a Debt-Free Community College Path

October 12, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Finletix
  • Home
  • AI
  • Financial
  • Investments
  • Small Business
  • Stocks
  • Tech
  • Marketing
Finletix
Home » Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher
Investments

Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher

arthursheikin@gmail.comBy arthursheikin@gmail.comSeptember 22, 2025No Comments3 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest Email

[ad_1]

(PRO Views are exclusive to PRO subscribers, giving them insight on the news of the day direct from a real investing pro. See the full discussion above.) Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market. Investors reacted by bidding shares of Pfizer higher in Monday morning trading, an atypical reaction to when a company is coughing up a big chunk of dough for an acquisition. “Getting into GLP land… it’s kind of been the Holy Grail for everybody,” said Tim Seymour of Seymour Asset Management in a special video for CNBC Pro (see above) . “I think’s it’s not surprising to see Pfizer rallying this morning because they had scrapped their own plans in GLP about five months ago.” PFE 1D mountain Pfizer, 1 day “Pfizer, over the course of the last four years, has made major acquisitions, especially in oncology and places where they really have diversified the business and took $30 billion of Covid windfall and tried to invest in the future,” the money manager added. With these recent acquisitions, Seymour is targeting $30 billion in additional revenue for Pfizer by 2030, that would represent about a 50% increase from revenue seen in the last 12 months Seymour also said the unique structure of the deal may be a reason for the positive reaction. Pfizer will not have to pay the full price tag unless certain clinical milestones are met by the Metsera oral and injectable weight loss treatments, including one that is only once a month. “They both can win,” said Seymour on the deal. PFE YTD mountain Pfizer, YTD Pfizer was trading above $24 a share on Monday. The money manager noted that he bought it in the high $30s so that’s obviously one reason he is cheering it on. Pfizer shares are off about 9% this year. Lastly, Seymour, who also manages the Amplify CWP International Enhanced Dividend Income ETF (IDVO) , likes the 7% dividend yield on the stock, which allows investors to get paid to wait for the comeback. Seymour in the Pro video also touches on: The AI stocks he likes as this bull market revs back up, including a “cheap” Alphabet Why the weak dollar is supporting the stock market A follow-up on the banks he liked going into the Fed rate cut and what he’s doing now The legitimacy of Goose as a jam band

[ad_2]

Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous ArticleElad Gil joins the stage at Disrupt 2025 in October
Next Article Generational opportunity in muni bonds is ‘slipping away,’ strategist says
arthursheikin@gmail.com
  • Website

Related Posts

These stocks reporting next week have a history of posting earnings beats and rallying

October 11, 2025

These stocks are now oversold after Trump tariff threat sparks sell-off

October 11, 2025

The stock market is diving on Trump’s threat of more China tariffs. Is this a good time to buy?

October 10, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Intel cuts 15% of its staff as it pushes to make a comeback

July 24, 2025

Tesla’s stock is tumbling after Elon Musk failure to shift the narrative

July 24, 2025

Women will soon be able to request a female Uber driver in these US cities

July 24, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Finletix — Your Insight Hub for Smarter Financial Decisions

At Finletix, we’re dedicated to delivering clear, actionable, and timely insights across the financial landscape. Whether you’re an investor tracking market trends, a small business owner navigating economic shifts, or a tech enthusiast exploring AI’s role in finance — Finletix is your go-to resource.

Facebook X (Twitter) Instagram Pinterest YouTube
Top Insights

French companies’ borrowing costs fall below government’s as debt fears intensify

September 14, 2025

The Digital Dollar Dilemma: Why Central Banks Are Rushing to Create Digital Currencies

September 1, 2025

FCA opens investigation into Drax annual reports

August 28, 2025
Get Informed

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

© 2026 finletix. Designed by finletix.
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms and Conditions

Type above and press Enter to search. Press Esc to cancel.